Cardiovascular events in eGFR-mutation non-small-cell lung cancer patients on osimertinibSamuel Akaakole Mensah, Syed Ahmad, Waleed Alruwaili, Rutu Raval, Karthik Gonuguntla, Brijesh Patel
26 October 2024
Adverse reactions to antimicrobials in pediatric patients admitted to a tertiary hospital: a cohort studyLuísa Rodrigues Furtado Leitzke, Gabriele Lenhart, Allan Lemos Rocha, Samantha Zamberlan, Diego Gnatta, Elisangela da Costa Lima, Isabela Heineck
27 June 2023
Risk of exposure of patients’ family members to lenalidomide at homeYuta Takahashi, Ayumu Nagamine, Akiko Kaneta, Hideaki Yashima, Kyoko Obayashi, Takuya Araki, Koujirou Yamamoto
20 June 2023
Reimagining the ADR Alert Card: a novel approach to recurrence prevention in low-cost settings for adverse drug reactionsSarita Mulkalwar, Uzair Khan, Shantanu Chitale, Abhijeet Tilak, Bhalchandra Rane, Abhi Patel
3 September 2024
Recommended doses of endovenous vancomycin are insufficient to achieve therapeutic concentrations in paediatric patientsIrene Aguilo Lafarga, María Pérez Moreno, Elena Herranz Bayo, Miriam Merchante Andreu, Rafael Huarte Lacunza
27 April 2023
Optimisation of the quality of care for patients with severe asthma: ASfarMA projectMaría Muñoz-García, Hilario Martínez-Barros, Silvia Sánchez-Cuéllar, Ana Morales-Tirado, Ana De-Andrés-Martín, Gonzalo De-Los-Santos-Granados, Darío Antolín-Amérigo, Enrique Blitz-Castro, Patricia Fernández-Martín, Alfonso Santamaría-Gadea, Belén De-La-Hoz-Caballer, Ana María Álvarez-Díaz, David González-De-Olano
3 February 2023
Patient reported medication-related problems, adherence and waste of oral anticancer medication over timePatricia M L A van den Bemt, Margriet Y Blijham, Laura ten Broek, Jacqueline G Hugtenburg, Bart P H Pouls, Job F M van Boven, Charlotte L Bekker, Bart van den Bemt, Liset van Dijk
17 July 2024
Risk assessment of clinical trial protocols: a tool for hospital pharmacists to reduce human error in experimental drug managementGiulia Cancellieri, Alessio Provenzani, Carlo Polidori, Piera Polidori
15 July 2024
Factors influencing the acceptability of different devices for subcutaneous drug delivery: a cross-sectional observational study from the patient’s point of viewLisa Pivato, Daniele Mengato, Federica Torni, Claudia Battistutta, Francesca Temporin, Francesca Venturini
21 February 2023
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New ZealandRebecca Larcombe, Kingsley Coulthard, Vaughn Eaton, Andrew Tai, Stephanie Reuter, Michael Ward
20 December 2022